Name: Functional Smart Nanomaterials and Their Theranostics Approaches
SKU: 64795203
Price: 147.87 USD
Availability: InStock
Author: Alle Madhusudhan;Shiv Dutt Purohit;Rajendra Prasad;Azamal Husen

portada Functional Smart Nanomaterials and Their Theranostics Approaches

Functional Smart Nanomaterials and Their Theranostics Approaches

Formato

Libro Físico

Editorial

Springer Verlag, Singapore

Autor

Alle Madhusudhan;Shiv Dutt Purohit;Rajendra Prasad;Azamal Husen

Colección

Smart Nanomaterials Technology

Año

2025

N° páginas

409

Encuadernación

Tapa Blanda

Dimensiones

23.5x15.5 cm

ISBN13

9789819965991

Functional Smart Nanomaterials and Their Theranostics Approaches

Alle Madhusudhan;Shiv Dutt Purohit;Rajendra Prasad;Azamal Husen (Autor) · Springer Verlag, Singapore · Tapa Blanda

Libro Nuevo Importado

Envío: 21 a 28 días háb.

$ 295.74$ 147.87

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan más de 100 unidades

$ 147.87

Llega entre el 21 Sep y el 02 Oct a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Functional Smart Nanomaterials and Their Theranostics Approaches"

This book covers a number of engineered nanotheranostics platforms and nanomedicines applications of FDA-approved medicines for early-stage diagnosis and treatment of cancer. The book focuses on (i) the basic design and bioengineering of safe medicines, (ii) physicochemical understanding of surface engineered medicines and their characteristics, (iii) various examples for site-specific bioimaging and multimode therapies, (iv) stimuli-responsive approaches for targeted drug delivery applications, (v) targeted therapeutics approaches for cancer cells or solid tumor ablations, (vi) targeted mechanisms of administrative biomedicines, (vii) impact of surface modification or engineering of biomedicines for site-selective tumor binding ability, and (vii) requirements for clinical trials and FDA approval. The content of this book appeal to readers who are interested in recent developments of FDA-approved cost-effective rapid cancer imaging and therapeutic platforms.